Helmut Jeggle is a businessperson who has been at the head of 22 different companies and is Chairman-Supervisory Board at BioNTech SE, Co-Managing Director at A&T Grundstück 2 GmbH, Managing Director at AT Newtec GmbH, Co-Managing Director at Jossa Arznei GmbH, Co-Managing Director at Palais Berlin 1 GmbH, Co-Managing Director at A&T Grundstück 1 GmbH, Co-Managing Director at Santo Service GmbH, Managing Director at Avitop GmbH, Co-Chief Executive Officer for Neuraxpharm Holding GmbH, Managing Director & Chief Financial Officer at Nx Biotech GmbH, Co-Managing Director at SWB Holding GmbH (Bayern), Managing Director at Horus Sentilo Projektentwicklungsgesellschaft mbH, Chief Executive Officer at Salvia GmbH, Chairman-Management Board at Sidroga AG, Chief Operating Officer & Co-Managing Director at Athos Service GmbH, Co-Managing Director at Santo Holding (Deutschland) GmbH, Co-Managing Director at Objektgesellschaft Berlin Passauer Straße 5-7 mbH, Co-Managing Director at Objektgesellschaft München Jahnstraße 41 und Klenzestraße, Managing Director at Santo Venture Capital GmbH, Chief Executive Officer at Athos KG and Managing Director at ATS Beteiligungsverwaltung GmbH. Helmut Jeggle is also Co-Managing Director at AT Impf GmbH and Managing Director at Apceth Biopharma Manufacturing Co. Gmbh and on the board of 5 other companies.

In the past he occupied the position of Managing Director at Klinge Pharma GmbH (Bayern), Managing Director at apceth Biopharma GmbH, Head-Business Planning & Analysis at Sandoz International GmbH and Head-Business Planning & Analysis at H e x a l AG.

Helmut Jeggle received an undergraduate degree from Neu-Ulm University of Applied Sciences and an MBA from Stuttgart Institute of Management & Technology GmbH.